Akums Drugs Inks Licensing Pact with Canadian Firm Triple Hair
By Rediff Money Desk, New Delhi Oct 16, 2024 12:41
Akums Drugs and Pharmaceuticals has signed a licensing agreement with Triple Hair Inc. to develop and market the Canadian firm's innovative products in India.
New Delhi, Oct 16 (PTI) Akums Drugs and Pharmaceuticals on Wednesday said it has inked a licensing pact with Canada-based Triple Hair Inc.
As per the terms of the agreement, the company has been granted exclusive rights to further develop and market the products recently innovated by Triple Hair Inc, in India, Akums Drugs and Pharmaceuticals said in a regulatory filing.
The company will undertake this development and commercialisation after obtaining the necessary regulatory approvals or requisite licenses in India, it added.
"The agreement grants the company exclusive right to use Triple Hair's intellectual property rights (patent) solely to carry out the studies and perform the services as stipulated in the agreement," the company said.
Further, the company will manage the commercial strategy to promote and offer Triple Hair's patented products to its own marketing partners and clients within the Indian market exclusively, it added.
Shares of Akums Akums Drugs and Pharmaceuticals were trading 4.31 per cent up at Rs 919 apiece on BSE.
As per the terms of the agreement, the company has been granted exclusive rights to further develop and market the products recently innovated by Triple Hair Inc, in India, Akums Drugs and Pharmaceuticals said in a regulatory filing.
The company will undertake this development and commercialisation after obtaining the necessary regulatory approvals or requisite licenses in India, it added.
"The agreement grants the company exclusive right to use Triple Hair's intellectual property rights (patent) solely to carry out the studies and perform the services as stipulated in the agreement," the company said.
Further, the company will manage the commercial strategy to promote and offer Triple Hair's patented products to its own marketing partners and clients within the Indian market exclusively, it added.
Shares of Akums Akums Drugs and Pharmaceuticals were trading 4.31 per cent up at Rs 919 apiece on BSE.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Srestha Finvest
- 0.71 (+ 4.41)
- 52384275
- AvanceTechnologies
- 0.98 (+ 4.26)
- 12816016
- Vodafone Idea L
- 7.85 ( -0.38)
- 12026789
- Suzlon Energy Ltd.
- 60.70 ( -2.88)
- 10094215
- ARC Finance
- 2.91 (+ 4.68)
- 9827710
MORE NEWS
Pepper, Copra & Ginger Prices in Mumbai
Get the latest prices of pepper, copra, and ginger in Mumbai. Check rates for black...
Sensex, Nifty Fall Amid FII Outflows, Weak...
Indian stock markets declined in early trade due to continuous foreign fund outflows,...
Rupee Hits All-Time Low at 84.38 vs US Dollar
The Indian rupee fell to a record low of 84.38 against the US dollar in early trade on...